Skip to main contentSkip to navigation
Sirius Investors

PHCUF Stock: Photocure ASA Stock Price, Analysis & Insights

Get live PHCUF stock price $6.18, comprehensive Photocure ASA stock analysis, charts, news, and expert forecast. Real-time PHCUF stock data and investment insights.

6.18
0.00%Today
PHCUFPhotocure ASA • Other OTC • Healthcare
Market Cap
164.43M
Volume
100
52W High
7.39
52W Low
4.95

Loading chart data...

Photocure ASA (PHCUF) Overview

Photocure ASA (PHCUF) is a publicly traded company in the Healthcare sector , specifically within the Biotechnology industry . As of the latest trading session, PHCUF trades at $6.18 with a market capitalization of 164.43M . Over the past 52 weeks, PHCUF has traded between $4.95 and $7.39 , with the current price positioned at approximately 50% of this range . The stock currently trades at a pr...

Key Takeaways

  • Operates in the Healthcare sector (Biotechnology)
  • Market cap: 164.43M
  • Current price: $6.18
  • 52-week range: $4.95 - $7.39
  • P/E ratio: 18.73

Investment Score

Annual (latest period)
Unavailable

A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.

Score unavailable for this asset.

0-39

Defensive posture

40-54

Mixed / wait for confirmation

55-69

Constructive setup

70-100

Attractive zone

Total Score

Value

Cheapness vs fundamentals and cash generation

Quality

Durability of profitability and balance sheet

Momentum

Price trend strength and persistence

Professional usage: treat the score as a ranking and risk-filtering tool, then confirm with earnings revision trend, competitive positioning, and valuation relative to peers before capital allocation.

Company Overview

Photocure ASA, a specialty pharmaceutical company established in Oslo, Norway in 1993, focuses on the entire lifecycle of pharmaceutical products, from research and development to manufacturing, distribution, and commercialization. The company's reac...

Company Information

CEO
Daniel Schneider
Sector
Healthcare
Industry
Biotechnology
Employees
99

Contact Information

Address
Hoffsveien 4
Country
NO

Investment Analysis & Business Insights

Healthcare
Biotechnology

Investment Highlights

Strong presence in the Healthcare sector with established market position

Valuation metrics suggest potential value opportunity (P/E: 18.7)

Lower volatility stock (Beta: 0.36) may provide portfolio stability

Important Investment Considerations

  • All investments carry risk, including potential loss of principal for Photocure ASA shareholders
  • Market volatility can significantly impact stock price, especially for smaller companies
  • Sector-specific risks in Healthcare may affect company performance
  • Past performance does not guarantee future results for Photocure ASA
  • Investors should consider how Photocure ASA fits within their overall portfolio allocation

Market Cap

164.43M

P/E Ratio (TTM)

18.73

Beta

0.36

Data Sources & Methodology

Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.

About Healthcare Sector

The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.